NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹3.23 Cr | ₹2.70 Cr | ₹2.55 Cr | ₹2.46 Cr | ₹2.11 Cr |
What is the latest Long Term Provisions ratio of NGL FINECHEM ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹3.23 Cr |
Mar2023 | ₹2.70 Cr |
Mar2022 | ₹2.55 Cr |
Mar2021 | ₹2.46 Cr |
Mar2020 | ₹2.11 Cr |
How is Long Term Provisions of NGL FINECHEM Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹3.23 Cr | 19.30 | |
Mar2023 | ₹2.70 Cr | 6.04 | |
Mar2022 | ₹2.55 Cr | 3.62 | |
Mar2021 | ₹2.46 Cr | 16.75 | |
Mar2020 | ₹2.11 Cr | - |
Compare Long Term Provisions of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹653.4 Cr | -26.6% | -34.4% | -38.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹411,102.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,137.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹118,974.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,112.0 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,991.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -26.6% |
-34.4% |
-38.9% |
SENSEX | -1.7% |
-0.8% |
5.8% |
You may also like the below Video Courses